TUESDAY, Jan. 11, 2022 (HealthDay News) — It’s a move that could severely limit the number of people taking the controversial new Alzheimer’s drug Aduhelm: Medicare on Tuesday proposed to only cover the cost of the pricey medication for people enrolled in approved clinical trials. A final decision on coverageContinue Reading

TUESDAY, Jan. 11, 2022 (HealthDay News) — For several years, a leading U.S. pediatricians’ group has called for middle and high schools to start later in the morning, to help these young people get the right amount of sleep. Now, new research suggests that students aren’t the only ones whoContinue Reading

FRIDAY, Jan. 7, 2022 (HealthDay News) — Following a months-long and unprecedented review, Medicare officials expect to announce within the next couple of weeks whether the program will cover the controversial Alzheimer’s drug Aduhelm. The drug’s benefits are in question and its annual price tag tops $28,000. The U.S. CentersContinue Reading

THURSDAY, Jan. 6, 2022 (HealthDay News) — A medication that acts on certain brain receptors can temporarily ease visual-processing problems in some adults with autism, a small study has found. Researchers said it’s far too early to know whether the drug, arbaclofen, could prove useful in managing those visual issues.Continue Reading